Company profile for Juno Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

More than 25 years ago, researchers at Fred Hutchinson Research Center, Memorial Sloan Kettering Cancer Center and Seattle Children’s Research Institute and elsewhere were working in the lab on the development of T cells against foreign antigens. This early work was ground breaking, ultimately defining the principles for producing investigational adoptive T cell therapy, and eventually, CAR T cells. By the mid-2000s, this re...
More than 25 years ago, researchers at Fred Hutchinson Research Center, Memorial Sloan Kettering Cancer Center and Seattle Children’s Research Institute and elsewhere were working in the lab on the development of T cells against foreign antigens. This early work was ground breaking, ultimately defining the principles for producing investigational adoptive T cell therapy, and eventually, CAR T cells. By the mid-2000s, this research moved into patient clinical trials.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
400 Dexter Avenue North Suite 1200 Seattle, WA 98109
Telephone
Telephone
206-582-1600
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
BMS, Pfizer turned away from SCOTUS in high-profile cases
BMS, Pfizer turned away from SCOTUS in high-profile cases

09 Jan 2023

// Kevin Dunleavy FIERCE PHARMA

https://www.fiercepharma.com/pharma/scotus-denies-bms-final-bid-rehear-appeal-against-gilead

Kevin Dunleavy FIERCE PHARMA
09 Jan 2023

https://www.fiercepharma.com/pharma/gilead-counters-bristol-myers-supreme-court-petition-patent-feud-car-t-outfits-kite-and-juno

Fraiser Kansteiner FIERCEPHARMA
26 Aug 2022

https://www.oxb.com/news-media/press-release/oxford-biomedica-expands-agreement-juno-therapeutics-bristol-myers-squibb

OXB
21 Jul 2022
BMS takes CAR-T patent case to US top court after appeals loss
BMS takes CAR-T patent case to US top court after appeals loss

17 Jun 2022

// Eric Sagonowsky FIERCEPHARMA

https://www.fiercepharma.com/pharma/bristol-myers-takes-its-car-t-patent-argument-us-top-court-bid-revive-12b-verdict-against

Eric Sagonowsky FIERCEPHARMA
17 Jun 2022
Indapta snags $50M and signs on former Juno exec as CEO
Indapta snags $50M and signs on former Juno exec as CEO

10 Feb 2022

// Max Bayer FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/indapta-tops-50m-series-a-taps-former-juno-exec-as-ceo-as-focus-turns-toward-clinical

Max Bayer FIERCEBIOTECH
10 Feb 2022

https://endpts.com/sister-to-junos-liso-cel-jws-relma-cel-lands-second-ever-car-t-approval-in-china/

Amber Tong ENDPTS
03 Sep 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty